What is Zenflow?
Zenflow, Inc. is a privately held medical device firm founded by Stanford University Biodesign Fellows in collaboration with leading urologists. The company is dedicated to enhancing the quality of life for patients experiencing urinary obstruction due to an enlarged prostate. Its core innovation, the Zenflow Spring System, utilizes a small, spring-like coil to gently prop open the urethra, restoring normal function while preserving patient anatomy. The Spring System is currently an investigational device and is not yet approved for commercial sale, indicating a focus on clinical validation and regulatory pathways.
How much funding has Zenflow raised?
Zenflow has raised a total of $79.4M across 3 funding rounds:
Series A
$31.4M
Series B
$24M
Series C
$24M
Series A (2018): $31.4M with participation from Medical Technology Venture Partners, Invus Opportunities, and F-Prime Capital Partners
Series B (2021): $24M led by Astia, Medical Technology Venture Partners, Golden Seeds, F-Prime Capital, SV Tech Ventures, Cloudstone Capital, and Invus
Series C (2024): $24M supported by Cook Medical, F-Prime Capital, and Invus
Key Investors in Zenflow
Cook Medical
Cook Medical is a privately held medical device manufacturer based in Indiana, known for its extensive range of healthcare products.
F-Prime Capital
F-Prime Capital is an investment firm established in 2002, focusing on healthcare and technology sectors with a team of investors, engineers, doctors, and scientists.
Invus
Invus Group, founded in 1985 and headquartered in New York City, is an investment firm providing financial advice, investment services, and consulting.
What's next for Zenflow?
With the recent infusion of major strategic capital, Zenflow is poised for significant advancements. The company's focus will likely shift towards completing clinical trials, securing regulatory approvals, and preparing for commercial launch. This substantial backing suggests an acceleration of its go-to-market strategy, potentially involving scaling manufacturing, expanding its commercial team, and initiating targeted marketing efforts. The enterprise-level funding indicates a transition towards later-stage development and market entry, aiming to establish the Zenflow Spring System as a leading solution in the urology market.
See full Zenflow company page
